North America Plasma Protein Therapeutics Market Report

North America Plasma Protein Therapeutics Market Size

The North America plasma protein therapeutics Market size was valued at USD 10,934.55 million in 2025 and is anticipated to reach USD 11,860.81 million in 2026 from USD 22,729.58 million by 2034, growing at a CAGR of 8.47% during the forecast period from 2026 to 2034.

The rising prevalence of autoimmune disorders, immune deficiency disorders, neurological and bleeding disorders are the primary reasons driving North America's expansion of the plasma protein therapeutics market. Along with these considerations, the growing geriatric population in North America is a significant driver of market expansion, as the old are more susceptible to neurological problems.

Furthermore, biotechnology and pharmaceutical businesses are increasing their efforts in research and development initiatives, encouraging market growth. The plasma protein segment's current research and development is expected to drive its utilization in various applications. In the subsequent years, the increased use of therapeutic protein medicines in treating a wide range of clinical complaints is expected to provide this market with unique growth prospects.

To improve patients' quality of life and ensure donor safety, the plasma protein business has relied on quality and innovations. Plasma obtained through apheresis or whole blood donation processing can be assembled or divided into plasma protein products containing one or more pure plasma proteins or directly transfused to patients.

However, factors such as tight processing requirements for plasma protein products and a lack of acceptable reimbursement mechanisms are hampering the market's expansion. Furthermore, plasma collection standards in underdeveloped countries do not meet the fractionator's needs. To maintain the quality of their operations, these places have strict laws and regulations, starting with the quality of the raw materials. Plasma fractionators are specifically designed for this purpose. In addition to the fact that it is a complicated technology, raw material costs and numerous safety requirements influence the cost of these things. As a result, maintaining access to plasma protein therapy requires appropriate funding.

REGIONAL ANALYSIS

Geographically, the North American regional market is likely to remain the leader in the global plasma protein therapeutics market throughout the forecast period. A growing number of people are suffering from autoimmune and neurological diseases, supporting market growth. The United States is expected to be the primary market in this region. In addition, budgets for healthcare are under increasing strain. Plasma protein therapies have been dragged into the landscape of Health Technology Assessments (HTA), including the prospective use of cost-utility analysis (CUA) to distribute reimbursement monies, thanks to funding through reimbursement pathways from commercial and public payers.

The region's growing senior population further expands the patient pool, as the elderly are more susceptible to neurological illnesses. Furthermore, favorable government initiatives, rising blood donor awareness, the availability of improved protein fractioning processes, higher per capita income in developed countries, and an increase in the number of research collaborations are all projected to boost market expansion in the region.

KEY MARKET PLAYERS

play a leading role in the North American Plasma Protein Therapeutics market include

• Grifols
• CSL Behring
• Baxter
• Kedrion
• China Biologics
• Octapharma
• Chengdu Institute of Biological Products
• Shire Plc

MARKET SEGMENTATION

This research report on the North America plasma protein therapeutics market has been segmented and sub-segmented into the following categories:

By Type

• Immunoglobulins
• Albumin
• Coagulation Factor
• Alpha-1 Proteinase Inhibitor
• Others

By Application

• Hemophilia
• Primary Immunodeficiency Disorder
• Idiopathic Thrombocytopenic Purpura
• Secondary Immunodeficiency
• Others

By Country

• The United States
• Canada
• Rest of North America